Why was it important to evaluate the current commercial drugs during Diakine® development?
The commercial drugs provide a very good reference point for novel molecule development. They are often used as comparators in drug development.
What were your challenges before finding Evidentic?
The use of biosimilars was just not good enough for our target audience, who wanted to see in-vivo data of our novel Diakine™ compared to a commercial therapeutic drug. We are very fortunate that we found Evidentic, as there were no other sources of therapeutic drugs that were readily available.
How did Evidentic help you?
We were able to effectively eliminate the questions by using the drug aliquots of therapeutic drugs from Evidentic to show the superiority of our Diakine™ in a mouse model. Evidentic provides quality products with exceptional customer service, which enables an early-stage startup such as Deka Biosciences to succeed.